Patents by Inventor Ira Sanders

Ira Sanders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease
    Patent number: 9504735
    Abstract: Compositions and methods of modulating cellular function and treatment of disease in mammals comprising locally administering a regulated SNARE inhibitor and a translocating agent to the mammal. Regulated SNARE inhibitors include clostridial neurotoxins, tetanus neurotoxin and their free light chain portions and IgA protease. Translocating agents include acids, encapsulating vectors, and transduction domains.
    Type: Grant
    Filed: November 5, 2010
    Date of Patent: November 29, 2016
    Inventor: Ira Sanders
  • Method and Device for the Treatment of Obstructive Sleep Apnea and Snoring
    Publication number: 20160338872
    Abstract: The device relates to methods and devices for the treatment of obstmctive sleep apnea syndrome.
    Type: Application
    Filed: October 27, 2014
    Publication date: November 24, 2016
    Inventor: Ira Sanders
  • Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact with the Corresponding Antigen
    Publication number: 20160206711
    Abstract: A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of a therapeutically effective amount of a neurotoxin (CnT) derived from Clostridia sp.
    Type: Application
    Filed: March 29, 2016
    Publication date: July 21, 2016
    Inventor: Ira Sanders
  • Equine airway disorders
    Patent number: 9352152
    Abstract: Airway disorders in a horse are relieved by electrical stimulation of the airway tissue. Particular disorders and techniques include electrical stimulation to relieve laryngeal hemiplegia. A pacemaker processor generates an electrical treatment signal to be applied to upper airway tissue of the horse for treating the upper airway disorder. One or more stimulation electrodes interfaces with the upper airway tissue for delivering the treatment signal to the upper airway tissue.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: May 31, 2016
    Assignees: MED-EL Elektromedizinische Geraete GmbH, Cornell University
    Inventors: Werner Lindenthaler, Ira Sanders, Norm G. Ducharme
  • Treatment of mammalian physiological reaction of IgE antibodies present in said mammal upon contact with the corresponding antigen
    Patent number: 9314513
    Abstract: A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of therapeutically effective amount of a neurotoxin (CnT) derived from Clostridia sp.
    Type: Grant
    Filed: March 24, 2014
    Date of Patent: April 19, 2016
    Inventor: Ira Sanders
  • Method and device for the treatment of obstructive sleep apnea and snoring
    Patent number: 8925551
    Abstract: The device relates to methods and devices for the treatment of obstructive sleep apnea syndrome.
    Type: Grant
    Filed: February 28, 2005
    Date of Patent: January 6, 2015
    Assignee: Linguaflex, Inc.
    Inventor: Ira Sanders
  • Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact with the Corresponding Antigen
    Publication number: 20140286930
    Abstract: A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of therapeutically effective amount of a neurotoxin (CnT) derived from Clostridia sp.
    Type: Application
    Filed: March 24, 2014
    Publication date: September 25, 2014
    Inventor: Ira Sanders
  • Treatment of asthma in mammals with clostridia neurotoxins
    Patent number: 8715620
    Abstract: A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of a therapeutically effective amount of a neurotoxin (CnT) derived from Clostridia sp.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: May 6, 2014
    Inventor: Ira Sanders
  • Method and device for the treatment of obstructive sleep apnea and snoring
    Patent number: 8408213
    Abstract: The device relates to methods and devices for the treatment of obstructive sleep apnea syndrome.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: April 2, 2013
    Assignee: Linguaflex, Inc.
    Inventor: Ira Sanders
  • Treatment of allergic otitis media in mammals with neurotoxins
    Patent number: 8349292
    Abstract: A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of a therapeutically effective amount of a neurotoxin (CnT) derived from Clostridia sp.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: January 8, 2013
    Inventor: Ira Sanders
  • Treatment of Nasal and Sinus Disorders
    Publication number: 20120251576
    Abstract: Disclosed herein are compositions and methods for treating nasal and sinus conditions, and symptoms thereof, with botulinum toxin (BoNT).
    Type: Application
    Filed: December 15, 2010
    Publication date: October 4, 2012
    Inventor: Ira Sanders
  • Methods and Devices for Treating Sleep Apnea and Snoring
    Publication number: 20120227748
    Abstract: Methods and devices to prevent and/or treat breathing disorders (e.g., upper airway disorders) in mammals related to impaired airflow are described. Methods and devices apply force to soft tissue that avoids obstruction of airflow in the mammel's airway. Breathing disorders that are avoided by the methods and/or devices include apnea.
    Type: Application
    Filed: November 18, 2011
    Publication date: September 13, 2012
    Inventor: Ira Sanders
  • Treatment of Sleep Disordered Breathing with Neurotoxin
    Publication number: 20120225094
    Abstract: Disclosed herein are compositions of neurotoxins and methods of their use for the treatment of sleep disordered breathing. In one embodiment of the present invention, a method of treating sleep breathing disorders comprising administering a therapeutically effective amount of Clostridia neurotoxin (CnT) or light chain thereof to a mammal in need thereof is disclosed.
    Type: Application
    Filed: November 9, 2010
    Publication date: September 6, 2012
    Inventor: Ira Sanders
  • Method and device for the treatment of obstructive sleep apnea and snoring
    Patent number: 8220467
    Abstract: The device relates to methods and devices for the treatment of obstructive sleep apnea syndrome.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: July 17, 2012
    Assignee: Linguaflex, Inc.
    Inventor: Ira Sanders
  • SKIN COSMESIS TREATMENT WITH CLOSTRIDIA NEUROTOXINS
    Publication number: 20120156189
    Abstract: Methods of using clostridial toxins and other biological agents to treat skin cosmesis in humans is provided. The disclosed methods provide beneficial effects in humans.
    Type: Application
    Filed: January 4, 2012
    Publication date: June 21, 2012
    Inventors: Ira Sanders, Rosemary Sanders
  • Skin cosmesis treatment with clostridia neurotoxins
    Patent number: 8202522
    Abstract: Methods of using clostridial toxins and other biological agents to treat skin cosmesis in humans is provided. The disclosed methods provide beneficial effects in humans.
    Type: Grant
    Filed: January 4, 2012
    Date of Patent: June 19, 2012
    Inventors: Ira Sanders, Rosemary Aquila-Sanders
  • TREATMENT OF HOLOCRINE GLAND DYSFUNCTION WITH CLOSTRIDIA NEUROTOXINS
    Publication number: 20120114697
    Abstract: Methods of using clostridial toxins and other biological agents to control holocrine gland dysfunction in humans is provided. In preferred embodiments the methods provide beneficial effects in humans.
    Type: Application
    Filed: August 27, 2010
    Publication date: May 10, 2012
    Inventors: Ira Sanders, Rosemary Sanders
  • Treatment of rosacea with clostridia neurotoxins
    Patent number: 8153139
    Abstract: Methods of using clostridial toxins and other biological agents to treat rosacea in humans is provided. The disclosed methods provide beneficial effects in humans.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: April 10, 2012
    Inventors: Ira Sanders, Rosemary Aquila-Sanders
  • TREATMENT OF MAMMALIAN PHYSIOLOGICAL REACTION OF IgE ANTIBODIES PRESENT IN SAID MAMMAL UPON CONTACT WITH THE CORRESPONDEING ANTIGEN
    Publication number: 20120071395
    Abstract: A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of a therapeutically effective amount of a neurotoxin (CnT) derived from Clostridia sp.
    Type: Application
    Filed: November 23, 2011
    Publication date: March 22, 2012
    Inventor: Ira Sanders
  • Method and Device for the Treatment of Obstructive Sleep Apnea and Snoring
    Publication number: 20120017920
    Abstract: The device relates to methods and devices for the treatment of obstructive sleep apnea syndrome.
    Type: Application
    Filed: September 30, 2011
    Publication date: January 26, 2012
    Applicant: Linguaflex, Inc.
    Inventor: Ira Sanders